CAMBRIDGE, Mass., June 7 /PRNewswire-FirstCall/ -- Idenix
Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that Jean-Pierre
Sommadossi, Ph.D., Idenix's chairman and chief executive officer, will
present a corporate overview at the upcoming Pacific Growth Equities Life
Sciences Growth Conference on Monday, June 12, 2006 at 9:00 a.m. PT at the
InterContinental Mark Hopkins Hotel in San Francisco, at the Goldman Sachs
27th Annual Global Healthcare Conference on Tuesday, June 13, 2006 at 8:40
a.m. PT at the Ritz Carlton Laguna Niguel, and at the Needham and Co. Fifth
Annual Biotechnology and Medical Technology Conference on Thursday, June
15, 2006 at 9:30 am ET at the New York Palace Hotel.
The live and archived webcasts of the presentations can be accessed
under "Calendar of Events" in the Idenix Investor Center at
http://www.idenix.com. The archived replays will be available on the Idenix
website for two weeks following the presentations.
About Idenix
Idenix Pharmaceuticals, Inc. is a biopharmaceutical company engaged in
the discovery and development of drugs for the treatment of human viral and
other infectious diseases. Idenix's current focus is on the treatment of
infections caused by hepatitis B virus, hepatitis C virus and human
immunodeficiency virus (HIV). Idenix's headquarters are located in
Cambridge, Massachusetts and it has drug discovery operations in
Montpellier, France and Cagliari, Italy.
Contacts:
Idenix Pharmaceuticals, Inc.
Amy Sullivan (617) 995-9838
Teri Dahlman (617) 995-9905
SOURCE Idenix Pharmaceuticals, Inc.
 back to top
Related links:
http://www.idenix.com
CONTACT:
Amy Sullivan, +1-617-995-9838, or Teri
Dahlman, +1-617-995-9905, both of Idenix Pharmaceuticals, Inc.
|
